Filing metadata

Accession number
0001209191-23-022954
Form type
Form 3
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Apr 04, 2023
Reporting period
Mar 02, 2023
Description
Initial ownership

Explore SEC Filings Hub